Incidence of Mycoplasma Genitalium in Urine Sample Testing for Gonorrhea and Chlamydia


  • James Hess Ed.D. Oklahoma State University Center for Health Sciences College of Osteopathic Medicine (OSU-COM)
  • Dr. Anil Kaul, M.D., DDS., MPH Professor - OSU Center for Health Sciences
  • Amanda Foster Laboratory Manager - OSU Center for Health Sciences


While gonorrhea (GC) and chlamydia (CT) are among the most prevalent sexually transmitted diseases, mycoplasma genitalium has been identified as a rapidly emerging infection.  The purpose of this study was to determine the prevalence of mycoplasma genitalium (MG), sometimes referred to as Mgen, in patients being tested for gonorrhea (GC) and chlamydia (CT).  Samples from random, de-identified patients being tested for GC and CT were run in four separate batches over a one year period of time. The samples were tested on the Panther® System, utilizing assays provided by Hologic Corporation.  Of the 658 samples tested, the following prevalence rates were found.  Gonorrhea represented 12 positives (1.82%); Chlamydia represented 37 positives (6.51%); Mycoplasma genitalium represented 57 positives (8.66%).  The number of MG positives was 4.75 times greater than GC and 1.54 times greater than that of CT.






Healthcare Administration